Nuclear transport of epstein-barr virus DNA polymerase is dependent on the BMRF1 polymerase processivity factor and molecular chaperone Hsp90

Journal of Virology

Volumn 87, Issue 11, 2013, Pages 6482-6491

  Kawashima, Daisuke ^a   Kanda, Teru ^a   Murata, Takayuki ^a   Saito, Shinichi ^a   Sugimoto, Atsuko ^a,b   Narita, Yohei ^a,b   Tsurumi, Tatsuya ^a  

^a AICHI CANCER CENTER HOSPITAL   (Japan)

^b NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BALF5 PROTEIN; BMRF1 PROTEIN; DNA POLYMERASE; HEAT SHOCK PROTEIN 90; SHORT HAIRPIN RNA; UNCLASSIFIED DRUG;

ARTICLE; CELL NUCLEUS; CELLULAR DISTRIBUTION; COMPLEX FORMATION; CONTROLLED STUDY; CYTOPLASM; DNA REPLICATION; EPSTEIN BARR VIRUS; HERPES SIMPLEX VIRUS 1; IMMUNOPRECIPITATION; NONHUMAN; NUCLEAR LOCALIZATION SIGNAL; PRIORITY JOURNAL; PROTEIN TRANSPORT; VIRUS GENOME; VIRUS REPLICATION;

ACTIVE TRANSPORT, CELL NUCLEUS; ANTIGENS, VIRAL; CELL NUCLEUS; DNA-BINDING PROTEINS; DNA-DIRECTED DNA POLYMERASE; EPSTEIN-BARR VIRUS INFECTIONS; HELA CELLS; HERPESVIRUS 4, HUMAN; HSP90 HEAT-SHOCK PROTEINS; HUMANS; PROTEIN BINDING; VIRAL PROTEINS;

EID: 84878180356     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.03428-12     Document Type: Article

References (47)

1. Baer R, Bankier AT, Biggin MD, Deininger PL, Farrell PJ, Gibson TJ, Hatfull G, Hudson GS, Satchwell SC, Seguin C, Tuffnell PS, Barrell BG. 1984. DNA sequence and expression of the B95-8 Epstein-Barr virus genome. Nature 310:207-211.
2. Daikoku T, Kudoh A, Fujita M, Sugaya Y, Isomura H, Shirata N, Tsurumi T. 2005. Architecture of replication compartments formed during Epstein-Barr virus lytic replication. J. Virol. 79:3409 -3418.
3. Fixman ED, Hayward GS, Hayward SD. 1995. Replication of Epstein- Barr virus oriLyt: lack of a dedicated virally encoded origin-binding protein and dependence on Zta in cotransfection assays. J. Virol. 69:2998- 3006.
4. Sugimoto A, Kanda T, Yamashita Y, Murata T, Saito S, Kawashima D, Isomura H, Nishiyama Y, Tsurumi T. 2011. Spatiotemporally different DNArepair systems participate in Epstein-Barr virus genome maturation. J. Virol. 85:6127- 6135.
5. Tsurumi T. 2001. EBV replication enzymes. Curr. Top. Microbiol. Immunol. 258:65- 87.
6. Tsurumi T, Daikoku T, Kurachi R, Nishiyama Y. 1993. Functional interaction between Epstein-Barr virusDNApolymerase catalytic subunit and its accessory subunit in vitro. J. Virol. 67:7648 -7653.
7. Tsurumi T, Daikoku T, Nishiyama Y. 1994. Further characterization of the interaction between the Epstein-Barr virus DNA polymerase catalytic subunit and its accessory subunit with regard to the 3=-to-5= exonucleolytic activity and stability of initiation complex at primer terminus. J. Virol. 68:3354 -3363.
8. Cho MS, Milman G, Hayward SD. 1985. A second Epstein-Barr virus early antigen gene in BamHI fragment M encodes a 48- to 50-kilodalton nuclear protein. J. Virol. 56:860-866.
9. Li JS, Zhou BS, Dutschman GE, Grill SP, Tan RS, Cheng YC. 1987. Association of Epstein-Barr virus early antigen diffuse component and virus-specified DNA polymerase activity. J. Virol. 61:2947-2949.
10. Murayama K, Nakayama S, Kato-Murayama M, Akasaka R, Ohbayashi N, Kamewari-Hayami Y, Terada T, Shirouzu M, Tsurumi T, Yokoyama S. 2009. Crystal structure of Epstein-Barr virus DNA polymerase processivity factor BMRF1. J. Biol. Chem. 284:35896 -35905.
11. Daikoku T, Kudoh A, Sugaya Y, Iwahori S, Shirata N, Isomura H, Tsurumi T. 2006. Postreplicative mismatch repair factors are recruited to Epstein-Barr virus replication compartments. J. Biol. Chem. 281:11422- 11430.
12. Zhang Q, Holley-Guthrie E, Dorsky D, Kenney S. 1999. Identification of transactivator and nuclear localization domains in the Epstein-Barr virus DNA polymerase accessory protein, BMRF1. J. Gen. Virol. 80:69 -74.
13. Tsurumi T, Kobayashi A, Tamai K, Yamada H, Daikoku T, Yamashita Y, Nishiyama Y. 1996. Epstein-Barr virus single-stranded DNA-binding protein: purification, characterization, and action on DNA synthesis by the viral DNA polymerase. Virology 222:352-364.
14. Gao Z, Krithivas A, Finan JE, Semmes OJ, Zhou S, Wang Y, Hayward SD. 1998. The Epstein-Barr virus lytic transactivator Zta interacts with the helicase-primase replication proteins. J. Virol. 72:8559-8567.
15. Alvisi G, Musiani D, Jans DA, Ripalti A. 2007. An importin alpha/betarecognized bipartite nuclear localization signal mediates targeting of the human herpes simplex virus type 1 DNA polymerase catalytic subunit pUL30 to the nucleus. Biochemistry 46:9155-9163.
16. Burch AD, Weller SK. 2005. Herpes simplex virus type 1 DNA polymerase requires the mammalian chaperone hsp90 for proper localization to the nucleus. J. Virol. 79:10740 -10749.
17. Bukau B, Weissman J, Horwich A. 2006. Molecular chaperones and protein quality control. Cell 125:443- 451.
18. Morimoto RI. 2008. Proteotoxic stress and inducible chaperone networks in neurodegenerative disease and aging. Genes Dev. 22:1427-1438.
19. Young JC, Agashe VR, Siegers K, Hartl FU. 2004. Pathways of chaperone- mediated protein folding in the cytosol. Nat. Rev. Mol. Cell Biol. 5:781-791.
20. Whitesell L, Lindquist SL. 2005. HSP90 and the chaperoning of cancer. Nat. Rev. Cancer 5:761-772.
21. Kudoh A, Fujita M, Kiyono T, Kuzushima K, Sugaya Y, Izuta S, Nishiyama Y, Tsurumi T. 2003. Reactivation of lytic replication from B cells latently infected with Epstein-Barr virus occurs with high S-phase cyclin-dependent kinase activity while inhibiting cellular DNA replication. J. Virol. 77:851- 861.
22. Katsumura KR, Maruo S, Wu Y, Kanda T, Takada K. 2009. Quantitative evaluation of the role of Epstein-Barr virus immediate-early protein BZLF1 in B-cell transformation. J. Gen. Virol. 90:2331-2341.
23. Maruo S, Yang L, Takada K. 2001. Roles of Epstein-Barr virus glycoproteins gp350 and gp25 in the infection of human epithelial cells. J. Gen. Virol. 82:2373-2383.
24. Tsurumi T. 1993. Purification and characterization of the DNA-binding activity of the Epstein-Barr virus DNA polymerase accessory protein BMRF1 gene products, as expressed in insect cells by using the baculovirus system. J. Virol. 67:1681-1687.
25. Tsurumi T, Kishore J, Yokoyama N, Fujita M, Daikoku T, Yamada H, Yamashita Y, Nishiyama Y. 1998. Overexpression, purification and helix- destabilizing properties of Epstein-Barr virus ssDNA-binding protein. J. Gen. Virol. 79:1257-1264.
26. Tsurumi T, Kobayashi A, Tamai K, Daikoku T, Kurachi R, Nishiyama Y. 1993. Functional expression and characterization of the Epstein-Barr virus DNA polymerase catalytic subunit. J. Virol. 67:4651- 4658.
27. Fujita N, Kubo A, Francisco PB, Jr, Nakakita M, Harada K, Minaka N, Nakamura Y. 1999. Purification, characterization, and cDNA structure of isoamylase from developing endosperm of rice. Planta 208:283-293.
28. Isomura H, Stinski MF, Kudoh A, Nakayama S, Murata T, Sato Y, Iwahori S, Tsurumi T. 2008. A cis element between the TATA box and the transcription start site of the major immediate-early promoter of human cytomegalovirus determines efficiency of viral replication. J. Virol. 82: 849-858.
29. Czar MJ, Galigniana MD, Silverstein AM, Pratt WB. 1997. Geldanamycin, a heat shock protein 90-binding benzoquinone ansamycin, inhibits steroid-dependent translocation of the glucocorticoid receptor from the cytoplasm to the nucleus. Biochemistry 36:7776 -7785.
30. Csermely P, Kajtar J, Hollosi M, Jalsovszky G, Holly S, Kahn CR, Gergely P, Jr, Soti C, Mihaly K, Somogyi J. 1993. ATP induces a conformational change of the 90-kDa heat shock protein (hsp90). J. Biol. Chem. 268:1901-1907.
31. Sullivan W, Stensgard B, Caucutt G, Bartha B, McMahon N, Alnemri ES, Litwack G, Toft D. 1997. Nucleotides and two functional states of hsp90. J. Biol. Chem. 272:8007- 8012.
32. Goodrich LD, Rixon FJ, Parris DS. 1989. Kinetics of expression of the gene encoding the 65-kilodalton DNA-binding protein of herpes simplex virus type 1. J. Virol. 63:137-147.
33. Kiehl A, Dorsky DI. 1991. Cooperation of EBV DNA polymerase and EA-D(BMRF1) in vitro and colocalization in nuclei of infected cells. Virology 184:330 -340.
34. Plachter B, Nordin M, Wirgart BZ, Mach M, Stein H, Grillner L, Jahn G. 1992. The DNA-binding protein P52 of human cytomegalovirus reacts with monoclonal antibody CCH2 and associates with the nuclear membrane at late times after infection. Virus Res. 24:265-276.
35. Chen Y, Ciustea M, Ricciardi RP. 2005. Processivity factor of KSHV contains a nuclear localization signal and binding domains for transporting viral DNA polymerase into the nucleus. Virology 340:183-191.
36. Agulnick AD, Thompson JR, Iyengar S, Pearson G, Ablashi D, Ricciardi RP. 1993. Identification of a DNA-binding protein of human herpesvirus 6, a putative DNA polymerase stimulatory factor. J. Gen. Virol. 74:1003- 1009.
37. Takeda K, Haque M, Nagoshi E, Takemoto M, Shimamoto T, Yoneda Y, Yamanishi K. 2000. Characterization of human herpesvirus 7 U27 gene product and identification of its nuclear localization signal. Virology 272: 394-401.
38. Alvisi G, Avanzi S, Musiani D, Camozzi D, Leoni V, Ly-Huynh JD, Ripalti A. 2008. Nuclear import of HSV-1 DNA polymerase processivity factor UL42 is mediated by a C-terminally located bipartite nuclear localization signal. Biochemistry 47:13764 -13777.
39. Alvisi G, Jans DA, Guo J, Pinna LA, Ripalti A. 2005. A protein kinase CK2 site flanking the nuclear targeting signal enhances nuclear transport of human cytomegalovirus ppUL44. Traffic 6:1002-1013.
40. Loregian A, Piaia E, Cancellotti E, Papini E, Marsden HS, Palu G. 2000. The catalytic subunit of herpes simplex virus type 1 DNA polymerase contains a nuclear localization signal in the UL42-binding region. Virology 273:139 -148.
41. Hur E, Kim HH, Choi SM, Kim JH, Yim S, Kwon HJ, Choi Y, Kim DK, Lee MO, Park H. 2002. Reduction of hypoxia-induced transcription through the repression of hypoxia-inducible factor-1alpha/aryl hydrocarbon receptor nuclear translocatorDNAbinding by the 90-kDa heat-shock protein inhibitor radicicol. Mol. Pharmacol. 62:975-982.
42. Ellis RJ, Hemmingsen SM. 1989. Molecular chaperones: proteins essential for the biogenesis of some macromolecular structures. Trends Biochem. Sci. 14:339 -342.
43. Sun X, Barlow EA, Ma S, Hagemeier SR, Duellman SJ, Burgess RR, Tellam J, Khanna R, Kenney SC. 2010. Hsp90 inhibitors block outgrowth of EBV-infected malignant cells in vitro and in vivo through an EBNA1- dependent mechanism. Proc. Natl. Acad. Sci. U. S. A. 107:3146 -3151.
44. Jeon YK, Park CH, Kim KY, Li YC, Kim J, Kim YA, Paik JH, Park BK, Kim CW, Kim YN. 2007. The heat-shock protein 90 inhibitor, geldanamycin, induces apoptotic cell death in Epstein-Barr virus-positive NK/Tcell lymphoma by Akt down-regulation. J. Pathol. 213:170 -179.
45. Kudoh A, Daikoku T, Sugaya Y, Isomura H, Fujita M, Kiyono T, Nishiyama Y, Tsurumi T. 2004. Inhibition of S-phase cyclin-dependent kinase activity blocks expression of Epstein-Barr virus immediate-early and early genes, preventing viral lytic replication. J. Virol. 78:104 -115.
46. Neckers L. 2006. Chaperoning oncogenes: Hsp90 as a target of geldanamycin. Handb. Exp. Pharmacol. 172:259 -277.
47. Pearl LH, Prodromou C, Workman P. 2008. The Hsp90 molecular chaperone: an open and shut case for treatment. Biochem. J. 410:439- 453.